Facebook Twitter RSS
  • Search this Website
 
Skip to content
  • About Us
    • Our Vision
    • Intervention Strategies
    • Member – Government Committees
    • Annual Reports
    • Our Trustees
    • Donors
    • FCRA Information
  • Our Work
    • Pandemics and COVID-19
      • Helplines
      • Statements
      • High Court Order
      • Articles
      • Community Voices
      • Relief & Other Support for Covid-19
      • Intersectional Feminist Framework
      • Consultations on Gender, Equity & Covid-19 Vaccines
      • Webinar Series Pandemics & Public Health
      • Webinar Series on Vaccine Research & Access
      • Webinars on Covid-19
      • Videos and Podcasts
    • Public Health & Right to Health
    • Surrogacy & ARTs
      • Conference Participation & Seminars
      • Workshops & Discussions
      • Reports & Studies
      • Consultations
      • Film / Media
      • Policy Level Advocacy
      • Publications
      • Media Resources
    • Gender Based Violence
    • Sexual and Reproductive Health
    • Ethics in Clinical Trials, Access to Medicines
    • Young Women and Mental Health
    • Bioethics
    • Early Marriage and Health
    • Population Policies & Two Child Norm
  • Publications
    • Research Reports
    • Consultation Reports
    • Policy Briefs
    • Capacity Building Tools
    • Fact Finding Reports
    • Articles and Edited Volumes
    • Posters
    • Films & Videos
  • Archives
    • Clinical Trials
      • General
      • Affordability
      • Availability & Accessability
      • Compensation
      • Informed Consent
      • Recuritment
      • Bioethics
      • Guidelines & Legislations
  • Photo Gallery
  • Contact
  • Internship
  • Support Us

Category: General

All clinical trials to be published under European law

  By admin Archives, Clinical Trials, General

Fiona Barry | Outsourcing-Pharma.com | 03-Apr-2014 Pharmaceutical companies will be made to publish all European clinical trials in a public database under a draft law passed by the European Parliament yesterday. Read full article Continue reading

Why Clinical Trials Aren’t Doing Much for the Health of Minorities

  By admin Archives, Clinical Trials, General

Health Editor | Health | News & Views | 21 March 2014 It’s been 20 years since Congress required that research funded by the U.S. National Institutes of Health (NIH) include minorities, but non-whites still account for less than 5… Continue reading

CDSCO analysis reveals prevalence of substandard drugs in India

  By admin Archives, Clinical Trials, General

Zachary Brennan | in-Pharma Technologist.com | 11-Mar-2014 Nearly a quarter of drugs made in Jammu & Kashmir and 10% of those produced in Himachal Pradesh are substandard according to new testing data published by CDSCO. Read full article Continue reading

Clinical trials in India: Where do we stand globally?

  By admin Archives, Clinical Trials, General

Sandhiya Selvarajan, Melvin George, Suresh S Kumar, Steven Aibor Dkhar | Perspectives in Clinical Research | PubMed Central (PMC) | NCBI | 2013 Jul-Sep; 4(3): 160–164 Aims: To evaluate the trend of clinical trials in India over the last 4 years… Continue reading

The Means or the End? Experiences of Clinical Trial “Subjects” in India

  By admin Archives, Clinical Trials, General

Sarojini Nadimpally, Vaibhao Ambhore, Deepa Venkatachalam, Jyoti Bajpai | Asian Bioethics Review, Vol 5, No 4 (2013) Read full article   Continue reading

Current Clinical Trial Scenario of India: Challenges and Solution

  By admin Archives, Clinical Trials, General

Dr Rajashree Devarakonda | Pharma Bio World | 16 July 2013 India was considered as one of the hubs for conducting major global multinational clinical trials. It still has the potential to establish itself as a hub for global Clinical… Continue reading

‹12345›»
  • Announcements

    • ​’Working hope: How ASHAs mediate between their communities and the health system’
    • Innovative practices to address GBV in the Asia Pacific region in the pandemic context 
    • Webinar: “Relooking local production and R&D: Why the TRIPS waiver is still relevant”
    • Short course: GBV & Health systems roles and accountability
    • Webinar on Intersectionality and Equity in Intellectual Property Rights in Healthcare
  • What’s New

    • ​’Working hope: How ASHAs mediate between their communities and the health system’
    • The Unravelling Pandemic: Envisioning our Intersectional Feminist Futures
    • Regulation of Surrogacy in India
    • Dignity in death or discrimination in death?
    • Exploring Intellectual Property and Access to Medicines from a Gender Approach
  • Training, Building Capacities and Leadership

    Our Trainings and Capacity Building activities facilitate mobilization and provide support towards organizing around health issues and promoting health rights. They contribute to … Read more »

  • Research

    Research is an integral component of Sama’s work. Research is carried out on issues that the organization is already advocating around or in situations where we feel that there is a need to initiate … Read more »

  • Advocacy

    Sama recognizes the critical role of advocacy in building collective understanding on various issues and to strengthen and sustain campaigns around them. Advocacy initiatives of Sama, including … Read more »

  • Knowledge Creation

    Sama undertakes Creation of Knowledge Resources and their Dissemination on different issues pertaining to women and health. This forms our core strategy on various issues and initiatives that Sama … Read more »

  • About Us
  • Our Work
  • Publications
  • Archives
  • Photo Gallery
  • Contact
  • Internship
  • Support Us
© Sama – Resource Group for Women and Health, 2021
Powered by Parabola & WordPress.
Facebook Twitter RSS